The FDA has issued a Class II drug recall (D-0376-2026) for ACME UNITED CORPORATION's Dynarex BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%). The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturing process. The affected product, manufactured for Dynarex Corporation, was distributed nationwide within the United States.

This recall signifies a significant product safety and manufacturing compliance issue. Companies involved in drug manufacturing must ensure adherence to CGMP standards to prevent similar recalls. While the document does not specify a compliance deadline for action by other entities, the ongoing nature of the recall implies immediate attention is required for any affected product in the supply chain. Failure to comply with recall procedures or CGMP can lead to further enforcement actions by the FDA.